Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.07M Sell
5,715
-627
-10% -$215K 0.73% 35
2026
Q1
$2.23M Sell
6,342
-185
-3% -$66K 0.81% 36
2025
Q4
$2.14M Sell
6,527
-819
-11% -$260K 0.78% 39
2025
Q3
$2.07M Sell
7,346
-56
-0.8% -$16.2K 0.76% 41
2025
Q2
$2.07M Buy
7,402
+267
+4% +$75.6K 0.81% 35
2025
Q1
$2.22M Buy
7,135
+119
+2% +$35.1K 0.92% 34
2024
Q4
$1.83M Buy
7,016
+454
+7% +$135K 0.75% 37
2024
Q3
$2.11M Buy
6,562
+194
+3% +$63.5K 0.86% 29
2024
Q2
$1.99M Buy
6,368
+440
+7% +$129K 0.96% 29
2024
Q1
$1.69M Buy
5,928
+855
+17% +$250K 0.72% 40
2023
Q4
$1.46M Buy
+5,073
New +$1.38M 0.62% 46

Other funds holding AMGN

BKM Wealth Management's AMGN Position: Q2 2026 in Review

BKM Wealth Management reduced its Amgen (AMGN) stake by 9.9% in Q2 2026, selling an estimated $215K and leaving 5,715 shares worth $2.07M. The position accounts for 0.73% of the portfolio, ranked #35.

BKM Wealth Management first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.23M in Q1 2026. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • BKM Wealth Management held 5,715 shares of Amgen worth $2.07M as of Q2 2026.
  • BKM Wealth Management sold 627 Amgen shares in Q2 2026, an estimated $215K.
  • Amgen made up 0.73% of BKM Wealth Management's portfolio in Q2 2026, its #35 holding.
  • BKM Wealth Management first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • BKM Wealth Management's Amgen position peaked at $2.23M in Q1 2026.
  • 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on BKM Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.